Aim: To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.
Method: We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.
Results: Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).
Conclusion: The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.
{"title":"Patient characteristics, antibiotic use, and in-hospital outcomes in patients with ischaemic colitis: A nationwide retrospective cohort study.","authors":"Yasuhiro Kano, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga","doi":"10.1111/codi.70385","DOIUrl":"10.1111/codi.70385","url":null,"abstract":"<p><strong>Aim: </strong>To describe patient characteristics, management and in-hospital outcomes of ischaemic colitis, and to compare the rates of surgery and in-hospital death between patients who did and did not receive antibiotics.</p><p><strong>Method: </strong>We retrospectively identified hospital admissions for ischaemic colitis between April 2016 and March 2023 from the Diagnosis Procedure Combination inpatient database in Japan. We described the overall patient characteristics, management practices and outcomes, which were stratified by antibiotic use. The primary outcome was a composite of receipt of surgery and in-hospital mortality. We examined the association between antibiotic use within the first 2 days of admission and the primary outcome occurring on or after day 3 of hospitalization using multivariable logistic regression analyses.</p><p><strong>Results: </strong>Among 111,750 eligible cases, 36.2% received antibiotics within the first 2 days of admission. Of them, 0.9% underwent surgery and 1.3% died during hospitalization. The primary outcome occurred in 2.1% of cases in the overall cohort (≤2 days: 0.6%; ≥3 days: 1.5%) and in 1.0% of cases who did not receive (≤2 days: 0.2%; ≥3 days: 0.8%) and 4.2% of cases who received antibiotics (≤2 days: 1.5%; ≥3 days: 2.7%). After covariate adjustment, antibiotic use was associated with higher odds of the primary composite outcome (adjusted odds ratio 1.98, 95% confidence interval: 1.77-2.21).</p><p><strong>Conclusion: </strong>The surgical rate and in-hospital mortality in ischaemic colitis were lower than previously reported. Antibiotic use was associated with higher odds of surgery and in-hospital mortality; however, this finding should be interpreted cautiously, given potential unmeasured confounding.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70385"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen
Background: The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.
Method: LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.
Results: A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.
Conclusion: LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.
背景:腹腔镜完整肠系膜切除术(LCME)相对于传统手术的肿瘤学益处经常受到单中心设计、小队列或短且不完整随访的挑战。本研究旨在研究以人群为基础的多中心LCME实施前后术后5年复发风险和术后30天并发症的差异。方法:LCME在2017年对所有结肠癌外科医生进行培训后在丹麦中部地区实施。通过丹麦结直肠癌组数据库确定实施前(2015-2016,pre -2016组)和实施后(2018-2019,post组)的结肠癌患者。术后5年复发率通过国家登记系统确定。竞争风险的aallen - johansen估计用于计算累积复发率。结果:在研究期间,共有1919例患者(PRE, n = 1024; POST, n = 895)接受了治愈性手术。PRE组5年累积复发率为16.1% (95% CI: 13.8, 18.4), POST组5年累积复发率为12.5% (95% CI: 10.2, 14.9),绝对风险差异为3.6% (95% CI: 0.3, 6.9)。此外,LCME实施后II期患者的危险复发率显著降低,危险率比为0.42 (95% Cl: 0.24, 0.72)。与PRE组相比,POST组发生严重术后并发症的风险也显著降低。结论:LCME的实施显著降低了复发风险和术后严重并发症的发生率。本研究表明,多中心LCME的实施可以在不影响患者安全的情况下改善临床结果。
{"title":"Five-year recurrence and postoperative complications after laparoscopic complete Mesocolic excision: A population-based, multicentred study.","authors":"Tora Haug, Jan Brink Valentin, Mai-Britt Worm Ørntoft, Lene Hjerrild Iversen, Søren Paaske Johnsen, Robin Kennedy, Danilo Miskovic, Anders Husted Madsen","doi":"10.1111/codi.70380","DOIUrl":"https://doi.org/10.1111/codi.70380","url":null,"abstract":"<p><strong>Background: </strong>The oncological benefits of Laparoscopic Complete Mesocolic Excision (LCME) over conventional surgery are often challenged by single-centre designs, small cohorts or short and incomplete follow-up. This study aimed to examine the difference in recurrence risk 5 years after surgery and 30-day postoperative complications before and after a population-based, multicentre LCME implementation.</p><p><strong>Method: </strong>LCME was implemented in the Central Denmark Region, Denmark following a training programme in 2017 for all colon cancer surgeons. Colon cancer patients from before (2015-2016, PRE-group) and after the implementation (2018-2019, POST-group) were identified through the Danish Colorectal Cancer Group Database. Recurrence 5 years after surgery was ascertained through national registers using a validated algorithm. The Aalen-Johansen estimator for competing risk was used to calculate cumulative incidence of recurrence.</p><p><strong>Results: </strong>A total of 1919 patients (PRE, n = 1024; POST, n = 895) underwent curative-intended surgery in the study period. The 5-year cumulative incidence of recurrence was 16.1% (95% CI: 13.8, 18.4) in the PRE group and 12.5% (95% CI: 10.2, 14.9) in the POST group, with a significant absolute risk difference of 3.6% (95% CI: 0.3, 6.9). Furthermore, a significantly lower hazard rate of recurrence was observed in stage II patients after the LCME implementation, with a hazard rate ratio of 0.42 (95% Cl: 0.24, 0.72). Risk of severe postoperative complications was also significantly lower in the POST, compared to the PRE group.</p><p><strong>Conclusion: </strong>LCME implementation was associated with a significantly lower risk of recurrence and lower rate of severe postoperative complications. This study indicates that multicentre LCME implementation may improve clinical outcomes without compromising patient safety.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70380"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Facilitating endorobotic submucosal dissection (ERSD) in transanal single-port surgery: A comparative analysis of two ports-A video vignette.","authors":"Ece Erenler, Metincan Erkaya, Mustafa Oruc, Salih Nafiz Karahan, Emre Gorgun","doi":"10.1111/codi.70400","DOIUrl":"https://doi.org/10.1111/codi.70400","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70400"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Felipe Mendes Delpino, Francisco Tustumi, Marina Martins Siqueira, Gabriely Rangel Pereira, Marcelo Passos Teivelis, Lucas Hernandes Correa, Nelson Wolosker
Background: Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.
Methods: We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.
Results: In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.
Conclusion: Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.
{"title":"Epidemiological profile of surgical treatment for colorectal cancer: Retrospective analysis of trends and regional disparities in Brazil, 2014-2024.","authors":"Felipe Mendes Delpino, Francisco Tustumi, Marina Martins Siqueira, Gabriely Rangel Pereira, Marcelo Passos Teivelis, Lucas Hernandes Correa, Nelson Wolosker","doi":"10.1111/codi.70387","DOIUrl":"https://doi.org/10.1111/codi.70387","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.</p><p><strong>Methods: </strong>We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.</p><p><strong>Results: </strong>In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.</p><p><strong>Conclusion: </strong>Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70387"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun
<p><strong>Aim: </strong>Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.</p><p><strong>Methods: </strong>Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a <3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.</p><p><strong>Results: </strong>Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p < 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).</p><p><strong>Limitations: </strong>Retrospective design and reliance on electronic medical records from a single institution.</p><p><strong>Conclusion: </strong>Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat
{"title":"Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis.","authors":"M Goldenshluger, M A Abbas, M Belkovsky, A Alipouriani, K Erozkan, G Alon, M A Valente, S R Steele, S D Holubar, D Liska, E Gorgun","doi":"10.1111/codi.70365","DOIUrl":"10.1111/codi.70365","url":null,"abstract":"<p><strong>Aim: </strong>Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized. This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.</p><p><strong>Methods: </strong>Retrospective cohort study using univariate and propensity-matched analyses. Data extracted from electronic medical records at a single tertiary institution [2001-2021]. Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a <3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.</p><p><strong>Results: </strong>Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (p < 0.001), and a higher American Society of Anaesthesiologists (ASA) score (p = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (p = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (p = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%-71%) and PRC (50.3%, 95% CI: 36%-64%) groups (p = 0.61).</p><p><strong>Limitations: </strong>Retrospective design and reliance on electronic medical records from a single institution.</p><p><strong>Conclusion: </strong>Patients with PPC developed SRC up to 10 years after radiation therapy. Patients with SRC were typically older with more comorbidities. Fewer patients with SRC underwent neoadjuvant therapy, and as a group, required more extensive surgeries with a lower rate of sphincter preservation compared to patients with PRC. Despite these differences, patients with SRC had similar pathological outcomes and overall survival compared to pat","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70365"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12852529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Assurance of rectal side arterial and venous perfusion with indocyanine green fluorescence angiography during anterior resection-A Video Vignette.","authors":"Ronan A Cahill","doi":"10.1111/codi.70394","DOIUrl":"10.1111/codi.70394","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70394"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146117889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.
Methods: A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.
Results: Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53-0.73; I2 = 0%; prediction interval 0.50-0.77) and clinically significant leak (RR 0.66, 95% CI 0.51-0.85; I2 = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50-0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73-1.05).
Conclusion: Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.
目的:吻合口漏是左侧结直肠切除术后的一个严重并发症,具有很高的发病率、死亡率和医疗费用。本系统综述和荟萃分析评估术中吲哚菁绿(ICG)荧光血管造影是否能降低左侧结肠直肠癌切除术患者的吻合口漏率。方法:对主要数据库和试验注册库进行系统检索,比较ICG血管造影和标准视觉评估在成人择期左侧结肠直肠切除术中的应用。主要结局是总体和临床显著(ISGRC分级B/C)吻合口漏。风险比(rr)采用随机效应模型汇总。采用Cochrane ROB2工具评估偏倚风险。结果:纳入10项试验,涉及3772例患者。与对照组相比,ICG荧光血管造影减少了吻合口总漏(RR 0.62, 95% CI 0.53-0.73; I2 = 0%;预测区间0.50-0.77)和临床显著漏(RR 0.66, 95% CI 0.51-0.85; I2 = 0%)。假设基线泄漏率为10%,ICG可防止每27名患者发生一次泄漏。亚组分析显示,即使ICG没有提示手术计划修改,也有益处(RR 0.67, 95% CI 0.50-0.90)。在所有分析中,研究间异质性可以忽略不计。使用ICG没有延长手术时间,减少了术后并发症(RR 0.88, 95% CI 0.73-1.05)。结论:术中ICG荧光血管造影可显著降低左侧结直肠切除术后吻合口漏率,在不同手术环境下均有一致的益处。该技术实用,不延长作业时间。ICG血管造影在左侧结肠直肠切除术中是一种有价值的辅助手段。
{"title":"Use of intraoperative ICG fluorescence angiography to reduce anastomotic leak in left-sided colorectal resections: A systematic review and meta-analysis of RCTs.","authors":"Ahmed Boalot, JihDar Yau, Mahmudul Hasan, Xuanping Wang, Amira Younes, Madeline Hannah, Muneer Junejo","doi":"10.1111/codi.70378","DOIUrl":"https://doi.org/10.1111/codi.70378","url":null,"abstract":"<p><strong>Aim: </strong>Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.</p><p><strong>Methods: </strong>A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.</p><p><strong>Results: </strong>Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53-0.73; I<sup>2</sup> = 0%; prediction interval 0.50-0.77) and clinically significant leak (RR 0.66, 95% CI 0.51-0.85; I<sup>2</sup> = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50-0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73-1.05).</p><p><strong>Conclusion: </strong>Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70378"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer
{"title":"TAMIS procedure for a recurrent rectal lesion at anastomotic site-A video vignette.","authors":"Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer","doi":"10.1111/codi.70389","DOIUrl":"10.1111/codi.70389","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70389"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Translating rectopexy practice variability into precision care innovative directions.","authors":"Zejun Song, Yiqi Guo","doi":"10.1111/codi.70391","DOIUrl":"10.1111/codi.70391","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":"e70391"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}